Canaccord sector valuations16 Oct 2022 18:50
Dear All – Canaccord published their quarterly O&G sector valuation tables on 14/10/22. As we’ve become accustomed, PANR continues to be the cheapest stock in Canaccord’s coverage on a risk/return basis. I’ll summarise below PANR’s metrics v’s the peer group of 16 UK listed companies.
PANR’s SP was 99p, v’s TP of 300p and labelled a Spec Buy. Brent assumptions for ’22 has reduced from $100 to $98; for ’23 from $90 to $85; for ’24 from $80 to $77. GBP v’s USD has moved from 1.25 to 1.20.
Upside to TP for PANR is 202%. For both Rockhopper and Southern it’s 179% and for Touchstone it’s 165%. The rest are all <111%.
One stock specific comment: “Alkaid drilling this summer was successful; initial flow test results due soon.”
PANR’s SP/central NAV is 99p/824p = 12%, v’s sector average of 50% and median of 49%.
PANR’s SP/full NAV is 99p/824p = 12%, v’s sector average of 46% and median of 46%.
PANR’s TP/NAV is 300p/824p = 36%. Orca Energy is the closest in that metric with 73%.
Ok, what’s this telling me? Well, IMHO, it shows that *for now* the market is perfectly happy to see PANR valued outside of the standard sector valuation metrics. The sheer scale of PANR’s discovery has an outsized effect on the calculations v’s the peer group. IMO the market is not only sceptical about the commerciality of PANR’s discovery but there’s an added layer of scepticism that the Oil in Place data is also questionable. FWIW the market is wrong about its OIP scepticism.
Whilst that’s kinda annoying for PANR shareholders who have been prepared to invest risk capital *before* the OIP data was confirmed by Theta West-1, AHS Baker Hughes and Schlumberger, it does offer an opportunity for those who are across the investment case when incoming news is published.
How so? If, and I repeat if, Alkaid-2 provides evidence of commerciality then the market will be *compelled* to begin to narrow the discount to fair value by not only re-examining the upside risk as it pertains to recoverable and contingent resources but also the upside risk provided by a re-assessment of the massive >23 bbo OIP declared by the company and its external consultants.
News? I’d have thought it’s possible we’ll hear something this week, maybe the week after? Stand by your alarm clocks! GLA